(Q35136173)

6 August 2017

In vitro activity of SCH-56592 and comparison with activities of amphotericin B and itraconazole against Aspergillus spp. (English)

1 reference

6 August 2017

1 reference

K L Oakley

1

1 reference

6 August 2017

C B Moore

series ordinal

2

1 reference

6 August 2017

D W Denning

series ordinal

3

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 May 1997

1 reference

Antimicrobial Agents and Chemotherapy

6 August 2017

1 reference

6 August 2017

41

1 reference

6 August 2017

5

1 reference

6 August 2017

1124-1126

1 reference

Activity of a new triazole, Sch 56592, compared with those of four other antifungal agents tested against clinical isolates of Candida spp. and Saccharomyces cerevisiae

6 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=163861

In vitro studies of activities of the antifungal triazoles SCH56592 and itraconazole against Candida albicans, Cryptococcus neoformans, and other pathogenic yeasts

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=163861

Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=163861

Therapeutic outcome in invasive aspergillosis

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=163861

NIAID Mycoses Study Group Multicenter Trial of Oral Itraconazole Therapy for Invasive Aspergillosis

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=163861

Comparative and collaborative evaluation of standardization of antifungal susceptibility testing for filamentous fungi

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=163861

Pulmonary aspergillosis in the acquired immunodeficiency syndrome

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=163861

In vitro susceptibility and synergy studies of Aspergillus species to conventional and new agents.

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=163861

Hydrocortisone-enhanced growth of Aspergillus spp.: implications for pathogenesis

13 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=163861

Antifungal activity of elutriated human monocytes against Aspergillus fumigatus hyphae: enhancement by granulocyte-macrophage colony-stimulating factor and interferon-gamma

27 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/9145880

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Effects of macrophage colony-stimulating factor on antifungal activity of mononuclear phagocytes against Aspergillus fumigatus

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/9145880

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Trends in the postmortem epidemiology of invasive fungal infections at a university hospital

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/9145880

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.41.5.1124

0 references

PMCID

163861

1 reference

6 August 2017

1 reference